Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Narrden
- Most recent report
- 10-Q, filed Nov 4, 2026
- Incorporated
- N/A
- Filings on record
- 415 filings
- On EDGAR
- CIK 1936258
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 41
News 8 of 50
Prospectuses and Registrations 8 of 36
- S-8 Registration statement for an employee plan Jun 5, 2026
- S-8 Registration statement for an employee plan Feb 18, 2026
- 424B3 Prospectus supplement for an offering Mar 10, 2025
- S-3 Shelf registration statement Feb 28, 2025
- S-8 Registration statement for an employee plan Jan 7, 2025
- 424B5 Prospectus supplement for an offering Dec 13, 2024
- 424B5 Prospectus supplement for an offering Dec 10, 2024
- POS AM Post-effective amendment to a registration Aug 9, 2024
Proxies 6
- DEF 14A Proxy statement for a shareholder vote May 6, 2026
- PRE 14A Preliminary proxy statement Apr 20, 2026
- DEF 14A Proxy statement for a shareholder vote May 8, 2025
- PRE 14A Preliminary proxy statement Apr 28, 2025
- DEF 14A Proxy statement for a shareholder vote May 9, 2024
- PRE 14A Preliminary proxy statement Apr 29, 2024
Ownership 8 of 211
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 5, 2026
- 4 Insider reported a trade Oct 2, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Sep 22, 2026
- 4 Insider reported a trade Sep 15, 2026
- 4 Insider reported a trade Sep 9, 2026
- 4 Insider reported a trade Sep 3, 2026
- 144/A Notice of a proposed sale of restricted stock, amended Aug 25, 2026
- 4 Insider reported a trade Aug 25, 2026
Other 8 of 71
- ARS Annual report sent to shareholders May 6, 2026
- ARS Annual report sent to shareholders May 8, 2025
- EFFECT Notice that a registration became effective Mar 10, 2025
- CORRESP Reply to SEC staff Mar 6, 2025
- UPLOAD Comment letter from SEC staff Mar 4, 2025
- S-3MEF Dec 11, 2024
- UPLOAD Comment letter from SEC staff Nov 1, 2024
- 20-F/A Annual report, foreign issuer, amended Oct 28, 2024
Everything here comes from NewAmsterdam Pharma Co N.V.'s own filings on SEC EDGAR. The filing list is rechecked every hour.